Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Coronary Interventions and Diagnostics · Cardiac Imaging and Diagnostics · Integrated Circuits and Semiconductor Failure Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. c-Myc activation in early coronary lesions in experimental hypercholesterolemia10.1006/bbrc.2001.4431 ↗
2. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury10.1161/01.CIR.90.2.944 ↗
3. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides10.1172/JCI117036 ↗
4. c-myc in vasculoproliferative disease10.1161/01.RES.76.2.176 ↗
5. Local delivery of c-myc neutrally charged antisense oligonucleotides with transport catheter inhibits myointimal hyperplasia and positively affects vascular remodelling in the rabbit balloon injury model
6. Kutryk · J Am Coll Cardiol · 2002 · 39 · 28110.1016/S0735-1097(01)01741-7 ↗
7. Localised arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution and bioactivity of forskolin10.1161/01.CIR.90.2.1003 ↗
8. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model10.1016/S0735-1097(96)00584-0 ↗
9. Effect on intimal hyperplasia of dexamethasone from coated metal stents compared with non-coated stents in canine femoral arteries10.1007/s002709900309 ↗
10. Local angiopeptin delivery using coated stents reduces neointimal proliferation in overstretched porcine coronary arteries
11. Angiopeptin-eluting stents: observations in human vessels and pig coronary arteries
12. Antithrombotic potential of polymer coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody10.1161/01.CIR.94.12.3311 ↗
13. Long-term effects of polymer-based, slow release, sirolimus-eluting stents in a porcine coronary model10.1016/j.cardiores.2004.04.029 ↗
14. Drug eluting stents: an early systematic review to inform policy10.1016/j.ehj.2004.03.023 ↗
15. Maintenance of long-term clinical benefit with sirolius-eluting coronary stents. Three year results of the RAVEL trail10.1161/01.CIR.0000156334.24955.B2 ↗
16. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation. Long term (up to 2 years) clinical, angiographic and intravascular ultrasound follow-up10.1161/01.CIR.0000034447.02535.D5 ↗
17. A randomised comparison of a Sirolimus-eluting stent with a standard stent for coronary revascularisation10.1056/NEJMoa012843 ↗
18. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery10.1056/NEJMoa035071 ↗
19. TAXUS 1: six- and twelve-month results from a randomised, double blind trial on a slow release paclitaxel-eluting stent for de novo coronary lesions10.1161/01.CIR.0000047700.58683.A1 ↗
20. A polymer based, paclitaxel-eluting stent in patients with coronary artery disease10.1056/NEJMoa032441 ↗
21. Drug eluting stents: current issues
22. Marked inflammatory sequelae to implantation of biodegradable and non-biodegradable polymers in porcine coronary arteries10.1161/01.CIR.94.7.1690 ↗
23. Phosphorylcholine coated metallic stents in rabbit iliac and porcine coronary arteries10.1080/14017439850139843 ↗
24. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility
25. Controlled delivery of antisense oligodeoxynucleotide from cationically modified phosphorylcholine polymer films10.1021/bm050840b ↗
26. Synthesis and characterisation of cationically modified phospholipids polymers10.1016/j.biomaterials.2003.09.082 ↗
27. Intravascular stents: a new technique for tissue processing for histology, immunohistochemistry and transmission electron microscopy10.1136/hrt.80.5.509 ↗
28. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model10.1016/0735-1097(92)90476-4 ↗
29. Insight into atherosclerosis: a review of c-myc and the vascular smooth muscle cell
30. Tissue-selective expression of dominant-negative proteins for the regulation of vascular smooth muscle cell proliferation10.1038/sj.gt.3300927 ↗
31. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
32. Stent-based sirolimus delivery reduces neointimal proliferation in a porcine coronary model of restenosis